Screener
Janux Therapeutics JANX Invested capital
Discontinued — last reported Q2 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Janux Therapeutics’s reported figures.
The source filing: Janux Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:18 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338078
FAQ
- What is Janux Therapeutics's invested capital?
- Janux Therapeutics (JANX) reported invested capital of $921.21M in Q2 2026.
- How has Janux Therapeutics's invested capital changed year-over-year?
- Janux Therapeutics's invested capital decreased by 4.1% year-over-year, from $960.26M to $921.21M.
- What is the long-term trend for Janux Therapeutics's invested capital?
- Over 4 years (2021 to 2025), Janux Therapeutics's invested capital has grown at a 29.4% compound annual growth rate (CAGR), from $330.94M to $926.63M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Janux Therapeutics's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude